GLP-2 TZ
GLP-2 TZ is a 39-amino acid dual GIP/GLP-1 receptor agonist developed for metabolic research, studied for its effects on glucose regulation, insulin sensitivity, and body weight reduction.
Free Shipping
over $200
Secure Checkout
256-bit SSL
Description
What is GLP-2 TZ?GLP-2 TZ is a synthetic 39-amino acid peptide that acts as a dual agonist of both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor, earning it the designation “twincretin.”
The peptide features non-coded amino acid substitutions that protect it from enzymatic degradation, and a C-20 fatty diacid moiety that enables once-weekly dosing by extending its half-life to approximately 5 days.
GLP-2 TZ has been approved by the FDA under multiple brand names. In clinical trials, it demonstrated significant reductions in HbA1c and body weight, often exceeding results seen with GLP-1 receptor agonists alone.
Research-grade GLP-2 TZ is not equivalent to FDA-approved formulations and is sold strictly for laboratory and research purposes only.
Research Applications
Areas of InvestigationDual Incretin Signaling
Body Weight Reduction
Glucose & Insulin Research
Liver & Lipid Research
Compound Profile
Technical specificationsMolecular Profile
Form
Storage & Stability
Storage (Pre-Reconstitution)
